Aman's Global Market Intelligence

1 · Executive dashboard

Trend strong · consumer signal weak

Regime call: neutral/selective risk-on. The S&P finished only 0.17% below Thursday's record and logged a third weekly gain while VIX fell to 14.25 and small caps rose. Against that, July retail sales fell 0.6%, Michigan sentiment dropped to 51.0, the official 10-year yield stayed at 4.68%, oil rose, and AI breadth fractured sharply. Inference: the index trend is constructive, but growth, duration and financing risk argue against indiscriminate chasing.

S&P 5007,785.76−0.17% Fri

Nasdaq Composite26,729.16−0.28%

Dow53,732.41−0.20%

Russell 20003,068.42+0.51%

VIX14.25−2.60% volatility

U.S. 2Y4.17%official Aug. 14

U.S. 10Y4.68%official Aug. 14

Dollar index99.64Friday reference

WTI$82.40+1.42%

Gold future~$4,433Friday reference

Region / index	Friday close / move	Read-through
Nikkei 225	68,713.80 · +0.59%	Japan strength; yen/BOJ repricing remains a risk.
Kospi	6,977.94 · +2.42%	Strongest major Asian close; chip sensitivity elevated.
Hang Seng	25,116.85 · −1.10%	Asia breadth remained split.
Shanghai Composite	3,927.18 · +0.01%	Essentially flat mainland session.
ASX 200	9,115.20 · −0.80%	Regional laggard.
DAX	26,440.31 · +0.53%	Europe outperformed Friday.
FTSE 100	10,750.11 · −0.21%	Oil support did not lift the broad index.
Euro Stoxx 50	6,539.59 · −0.09%	Near-flat risk appetite.

1 · Consumer deceleration

Census reported July sales of $763.6B, −0.6% m/m versus +0.1% consensus cited by Reuters; core control-group sales fell 0.4%. The miss was broad enough to cut Q3 growth estimates, though earlier Prime Day timing and lower gasoline prices contributed.

2 · Inflation psychology worsened

Michigan sentiment fell from 55.2 to 51.0; one-year inflation expectations rose to 4.3% from 4.2%, while long-run expectations held at 3.3%. That is a poor growth/inflation mix even as near-term Fed-hike odds eased.

3 · AI financing scrutiny

Reuters/WSJ said NVIDIA may initially guarantee under $120B for an Ohio OpenAI project versus $250B discussed earlier. The project remains large; the changed backstop highlights balance-sheet and counterparty discipline.

2 · Market drivers and rotation

Facts first; inference labeled

Macro, rates and central banks

Retail sales fell 0.6% m/m and 2.2% at nonstore retailers; restaurants rose 0.5%. This is slowing, not a clean recession signal.
Official Treasury closes were 4.17% (2Y) and 4.68% (10Y), leaving a +51 bp curve. Long-duration multiples still face a high hurdle.
Reuters reported markets priced roughly 69.4% odds of no September Fed change and 30.6% odds of a hike after the data. Those probabilities are snapshots, not forecasts.
The FOMC minutes on Aug. 19 are next week's key policy gate; import prices, industrial production and housing provide growth/inflation detail.

Geopolitics, energy and earnings

WTI rose to about $82.40 after a reported tanker attack near the Persian Gulf. Energy remains the clearest upside-inflation tail risk.
Friday rotation was extreme: AMD +6.50%, MU +2.30% and SMCI +1.74%, but AVGO −5.94%, AMAT −5.12% and CBRS −5.21%.
Inference: AI demand has not disappeared; investors are differentiating compute roadmaps, funding exposure, gross margins and post-earnings expectations.
Next week's retailer reports test whether July weakness was calendar noise or a broader household slowdown.

3 · Theme dashboards

AI / semis / cloud Leadership fragmented

Leaders: AMD $514.39 (+6.50%), MU $971.66 (+2.30%), SMCI $39.84 (+1.74%).
Laggards: AVGO $392.99 (−5.94%), AMAT $507.18 (−5.12%), CBRS $218.98 (−5.21%).
NVDA closed about $225.16, nearly flat; Aug. 26 earnings against a $91B revenue guide are the major 30-day gate.
Primary baseline: Q1 data-center revenue was $75.2B (+92% y/y), but China compute was excluded from Q2 guidance.
Risks: financing, customer concentration, power, export controls, margins and valuation.

Quantum Speculative / venture-like

No fresh, material company release was verified Friday that changes the basket thesis.
IonQ's last primary quarter showed $80.05M revenue (+287% y/y), $120.3M adjusted EBITDA loss and $254.8M six-month operating cash use.
Sep. 8 Investor Day remains the next focused IonQ gate.
Require independently verified technical milestones, repeatable contracts and controlled cash use—not sector sympathy.
Risks: roadmap slippage, acquisitions, stock compensation, dilution/warrants, lumpiness and extreme volatility.

Peptide / metabolic biotech Commercial quality vs binary risk

Friday: LLY $1,180.16 (−2.25%), NVO $45.89 (−1.78%), VKTX $33.19 (+0.76%).
Viking primary evidence: Phase 3 VANQUISH-1/2 are fully enrolled; primary endpoint is percent weight change at 78 weeks; oral Phase 3 is planned for Q4.
VKTX's prior Phase 2 weekly study reached up to 14.7% mean weight reduction after 13 doses; prior success may not replicate over Phase 3.
Q3 maintenance-dosing data are a binary, date-unspecified catalyst; cash/investments fell to $502M from $706M over six months while Q2 net loss was $128M.
Risks: GI tolerability/dropouts, safety, manufacturing, reimbursement, competition, regulatory delay, cash burn and dilution.

4 · Ranked ideas

Conditional paper setups; fewer is better

#1 NVDA · NVIDIA Conditional bullish

Nasdaq · mega-cap AI compute/networking · premium valuation / export / event-gap risk

Day trade: Mon only after breadth confirmation1–4 weeks: applicable, earnings-sized3–12+ months: applicable, volatility-sized

Uncertain direction / thesis: Friday's near-flat $225.16 close held the prior $220–224 breakout zone despite financing scrutiny and broad chip dispersion. AI demand evidence is strong, but Aug. 26 converts the setup into event risk.

Catalyst / evidence: Q1 revenue $81.6B and data center $75.2B; Q2 revenue guide $91B ±2%. AMD/memory strength and AMAT packaging demand corroborate infrastructure spending.

Counterargument: a less expansive OpenAI backstop shows financing discipline is becoming material; customer funding, China/export limits and a huge earnings hurdle can compress the multiple.

Entry / confirmation: orderly hold above $224 or reclaim after a $220–224 retest, with SOXX breadth improving. Do not chase above Friday's $227.49 high without volume.

Invalidation / downside: close below $216; material earnings/order disappointment; adverse export rule; or multiple AI leaders breaking post-results lows.

Key risks: earnings gap, valuation, concentration, financing, HBM/supply, power and competition.

Confidence

Risk

Opportunity

#2 CBRS · Cerebras Systems Avoid / no short claim

Nasdaq · newly public high-risk AI semiconductor/cloud · limited public history / squeeze risk

Day trade: unsuitable for most1–4 weeks: avoid until base3–12+ months: milestone watch only

Uncertain direction / thesis: Friday's $218.98 close (−5.21%) extended the post-earnings reset. Raised guidance and abundant cash can produce violent rebounds, so this is an avoid—not a borrow or short recommendation.

Evidence / catalyst: Q2 headline growth was strong, but revenue missed reported expectations and adjusted gross margin compressed. Friday volume was about 14.6M versus 6.9M average on Yahoo.

Counterargument: fast cloud growth, raised annual guidance and $7.9B reported cash could support scaling and a reversal.

Confirmation to upgrade: several sessions above $215–220, reclaim $231 with lower sell volume, and repeatable margin improvement.

Invalidation / downside: avoid stance is invalidated by a durable base plus execution beats; downside worsens below Friday's $215.78 low.

Key risks: price discovery, customer concentration, foundry/manufacturing scale, margins, dilution and squeeze risk.

Confidence

Risk

Opportunity

#3 CRWV · CoreWeave Avoid chase · not a short

Nasdaq · high-risk AI cloud · leverage / capex / concentration / squeeze risk

Day trade: only with defined stop1–4 weeks: wait for base3–12+ months: financing watch

Uncertain direction / thesis: $105.26 Friday (−0.97%) held above $100 after the earnings gap, but the capital structure still offers weak downside protection despite demand.

Evidence / catalyst: SEC exhibit shows Q2 revenue $2.575B, backlog ~$104B, net loss $626M and net interest expense $640M.

Counterargument: 1.5 GW active power, 3.7 GW contracted power and backlog can drive scale; adjusted EBITDA was $1.51B.

Confirmation to upgrade: stable base above $100, funded capex, lower interest burden and credible free-cash conversion.

Invalidation / downside: avoid stance changes on durable positive free cash flow; downside worsens on a close below $100/post-result gap support.

Key risks: refinancing, dilution, customers, power delivery, utilization, GPU supply and squeezes. No borrow representation.

Confidence

Risk

Opportunity

Watchlist · five maximum

AMD Momentum / do not chase

Nasdaq · large-cap AI semiconductor · C/R/O 76/84/61. $514.39, +6.50% Friday. A first pullback that holds $483–500 or a volume-backed break above $515 may confirm; failure below $483 weakens it. Risks: extreme valuation/momentum, NVIDIA competition, supply and export policy.

AMAT Price discovery

Nasdaq · large-cap equipment · C/R/O 88/79/58. $507.18, −5.12%, but above the $497.10 intraday low. Record results support the long view; UBS cut its target and the tape rejected the print. Require a base above $500 and reclaim of $523; below $497 deteriorates.

LLY Breakdown risk

NYSE · mega-cap peptide leader · C/R/O 84/72/48. $1,180.16, −2.25%, below both $1,200 and the prior $1,220 trigger. No bullish re-entry until $1,200–1,220 is reclaimed. Commercial quality is high; valuation, competition, access, manufacturing and pipeline events matter.

IONQ Extreme-risk quantum

NYSE · speculative quantum · C/R/O 78/96/47. Sep. 8 Investor Day is the focused gate. Q2 revenue growth is meaningful, but heavy losses, cash use, stock compensation and integration risk make a stable base and funded roadmap mandatory.

VKTX Small-cap binary biotech

Nasdaq · small-cap clinical biotech · C/R/O 76/97/55. $33.19, +0.76% Friday. Q3 maintenance data can move the stock sharply. Require protocol/statistical disclosure, tolerability/dropouts and cash-runway review; below $32 is technical deterioration. Phase 3 duration, safety, competition and dilution dominate.

5 · Audit of Aug. 14 published calls

No hindsight · paper only

Prior call	Friday evidence	Audit result	Change
NVDA conditional bullish; hold $220–224	~$225.16, −0.06%; low $224.50	Condition held, minimal favorable movement	Retain; risk score rises into Aug. 26 and financing headline.
AMAT avoid opening chase / wait	Opened $498.44, low $497.10, closed $507.18 (−5.12%)	Discipline validated; not a short call	Move to watch: stabilization began, but $523 reclaim needed.
CBRS avoid / price discovery	$218.98, −5.21%, on above-average volume	Avoid stance validated; no short P&L claimed	Retain avoid; Friday low $215.78 is next risk marker.
CRWV avoid chase / not short	$105.26, −0.97%	Correctly avoided momentum pursuit; little directional edge	Retain avoid pending base and financing progress.
LLY watch after failed $1,220 hold	$1,180.16, −2.25%	Further deterioration confirmed downgrade	Require $1,200–1,220 reclaim; no dip-buy ranking.
SMCI watch, extended	$39.84, +1.74%	Momentum continued; waiting reduced chase risk	Leaves active five-name list; no new edge after extension.
NVO / VKTX watch	NVO −1.78%; VKTX +0.76%	Mixed; no catalyst confirmation	VKTX stays for Q3 data; NVO leaves active list.

Calibration note: these are condition audits, not realized returns. “Avoid” is not equivalent to being short, and no execution, slippage, tax, financing or borrow assumptions are made. The initial two weeks remain paper-tracking.

6 · Important 7–30 day catalysts

Times ET · verify before execution

Mon Aug. 17 · 08:30 — Empire State manufacturing

First U.S. activity test after weak retail sales.

Tue Aug. 18 · 08:30–10:00 — Import/export prices; housing starts/permits; industrial production; Home Depot Q2

Inflation, construction, factory and household-improvement demand. Home Depot IR confirms Aug. 18.

Wed Aug. 19 · 10:00 / 14:00 — Analog Devices results; FOMC minutes

Analog/mixed-signal cycle and policy reaction-function. ADI IR and Federal Reserve.

Aug. 19–20 — Target, Lowe's, Walmart, Alibaba results

Consumer, housing, China commerce and cloud read-through. Treat third-party calendar timing as provisional until each IR page confirms.

Thu Aug. 20 — Initial claims, Philadelphia Fed, leading indicators

Growth confirmation or challenge after July's spending/jobs weakness.

Wed Aug. 26 · premarket macro / after close company — GDP second estimate, PCE, durable goods; NVIDIA results

The largest combined rates-and-AI valuation gate in the 30-day window.

Fri Aug. 28 · 10:00 — Final Michigan sentiment

Confirm whether preliminary 51.0 and 4.3% one-year inflation expectations persist.

Q3 2026 · date not specified — Viking VK2735 maintenance-dosing data

Binary small-cap biotech catalyst: weight maintenance, dosing arms, discontinuations, GI adverse events, estimand/statistics and cash use matter.

Tue Sep. 8 — IonQ Investor Day

Roadmap, technical milestones, SkyWater integration, revenue quality and cash-use gate.

7 · Bottom line by horizon

Day trade · Monday

Let the opening range absorb weak-consumer and AI-financing headlines. Prefer NVDA holding $224 and broad semiconductor participation; do not chase AMD's Friday gap or assume AMAT $500 holds. Avoid CBRS/CRWV unless using tightly defined event-risk stops.

1–4 week swing

NVDA is the only ranked conditional long, but size for Aug. 26. AMD and AMAT require pullback/base confirmation. LLY must reclaim $1,200–1,220. VKTX is catalyst speculation, not a routine swing.

3–12+ month investment

Favor cash-generative AI and peptide leaders over leveraged clouds, newly public price discovery and pre-profit quantum. NVDA, AMAT and LLY have the best business evidence, but valuation and entry still matter.

Biggest risk: oil/geopolitical stress holds inflation expectations high while consumer and labor data weaken, producing stagflationary multiple compression. Risk-on validation: 10Y below 4.60%, WTI back below $80, broad semiconductor recovery and retailers holding guidance. Invalidation / downgrade: 10Y above 4.80%, WTI above $85, VIX above 17, S&P loss of the prior week's breakout, or cascading AI post-earnings failures.

Sources & data quality

Data-quality panel

Cutoff and date were generated live with TZ=Europe/Rome date: 2026-08-15 08:30 CEST.
U.S. index closes were cross-checked across WSJ/FactSet and Yahoo. Focused stock closes/ranges came from Yahoo quote pages; material moves were cross-checked against market reporting.
VIX 14.25 was confirmed by Cboe's official dashboard and history CSV. Treasury's official Aug. 14 CSV gave 4.17% (2Y) and 4.68% (10Y).
Global index references and DXY were Friday Yahoo exchange-fed closes. WTI $82.40 was cross-checked with market reporting; gold ~$4,433 is a rounded Friday futures reference and not a spot quote.
Nasdaq API retries timed out for SPX and all 12 focused symbols; Yahoo chart API returned HTTP 429. Yahoo pages, Cboe, Treasury, Census, Michigan, SEC/company IR, Reuters and WSJ succeeded, so no price or catalyst was invented.
Saturday cash markets are closed; there are no live Asian closes, European cash prices or U.S. futures to report. Conditional technical levels are decision markers, not guarantees. Confidence measures evidence quality—not probability of profit.